Ewa Robak

2.3k total citations
97 papers, 1.7k citations indexed

About

Ewa Robak is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Ewa Robak has authored 97 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 29 papers in Immunology and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Ewa Robak's work include Systemic Lupus Erythematosus Research (43 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Lymphoma Diagnosis and Treatment (15 papers). Ewa Robak is often cited by papers focused on Systemic Lupus Erythematosus Research (43 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Lymphoma Diagnosis and Treatment (15 papers). Ewa Robak collaborates with scholars based in Poland, United States and Canada. Ewa Robak's co-authors include Tadeusz Robak, Anna Sysa‐Jędrzejowska, H Stępień, Anna Woźniacka, Anna Korycka, Ewa Lech‐Marańda, Piotr Smolewski, Jarosław Bogaczewicz, Agnieszka Wierzbowska and Jacek Bartkowiak and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Ewa Robak

91 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa Robak Poland 24 757 673 381 333 304 97 1.7k
Jacques Tébib France 25 669 0.9× 1.3k 1.9× 208 0.5× 402 1.2× 246 0.8× 91 2.3k
Frances Humby United Kingdom 22 864 1.1× 1.1k 1.7× 204 0.5× 354 1.1× 139 0.5× 60 2.2k
Jerzy Świerkot Poland 22 438 0.6× 795 1.2× 135 0.4× 254 0.8× 213 0.7× 99 1.5k
Scott W. Baumgartner United States 16 766 1.0× 1.4k 2.0× 164 0.4× 343 1.0× 232 0.8× 18 2.5k
Carla A. Wijbrandts Netherlands 30 1.1k 1.4× 1.7k 2.6× 275 0.7× 443 1.3× 369 1.2× 47 2.9k
J S Smolen Austria 22 614 0.8× 1.3k 1.9× 213 0.6× 153 0.5× 116 0.4× 39 1.8k
Seung Cheol Shim South Korea 24 591 0.8× 586 0.9× 132 0.3× 386 1.2× 77 0.3× 100 1.5k
Jonathan S. Coblyn United States 21 443 0.6× 1.2k 1.8× 189 0.5× 199 0.6× 368 1.2× 34 2.1k
Alberta Hoi Australia 23 1.7k 2.2× 1.9k 2.8× 313 0.8× 297 0.9× 96 0.3× 79 2.7k
Sergio Schwartzman United States 21 548 0.7× 955 1.4× 163 0.4× 103 0.3× 127 0.4× 59 1.4k

Countries citing papers authored by Ewa Robak

Since Specialization
Citations

This map shows the geographic impact of Ewa Robak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Robak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Robak more than expected).

Fields of papers citing papers by Ewa Robak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Robak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Robak. The network helps show where Ewa Robak may publish in the future.

Co-authorship network of co-authors of Ewa Robak

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Robak. A scholar is included among the top collaborators of Ewa Robak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Robak. Ewa Robak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robak, Tadeusz, et al.. (2024). Primary Cutaneous CD30-Positive Lymphoproliferative Disorders—Current Therapeutic Approaches with a Focus on Brentuximab Vedotin. Journal of Clinical Medicine. 13(3). 823–823. 4 indexed citations
2.
Woźniacka, Anna, et al.. (2024). Psoriasis and Lupus Erythematosus—Similarities and Differences between Two Autoimmune Diseases. Journal of Clinical Medicine. 13(15). 4361–4361. 1 indexed citations
3.
4.
Czajkowski, Rafał, et al.. (2021). Variability of the rs333 in Polish patients with lupuserythematosus. Advances in Dermatology and Allergology. 38(1). 131–136.
5.
Sokołowska‐Wojdyło, Małgorzata, Joanna Maj, Ewa Robak, et al.. (2017). Primary cutaneous lymphomas – diagnostic and therapeutic guidelines of the Polish Dermatological Society. Dermatology Review. 3. 243–268. 4 indexed citations
6.
Sobów, Tomasz, Jarosław Bogaczewicz, Jakub Ząbek, et al.. (2013). Zaburzenia psychiczne w toczniu rumieniowatym układowym. SHILAP Revista de lepidopterología.
7.
8.
Robak, Ewa, et al.. (2009). Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus. Lupus. 18(4). 332–341. 19 indexed citations
9.
Robak, Ewa & Tadeusz Robak. (2007). Skin lesions in chronic lymphocytic leukemia. Leukemia & lymphoma. 48(5). 855–865. 101 indexed citations
10.
Wierzbowska, Agnieszka, Tadeusz Robak, Agnieszka Pluta, et al.. (2007). Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients. Annals of Hematology. 87(2). 97–106. 17 indexed citations
11.
Robak, Tadeusz, Ewa Lech‐Marańda, Anna Korycka, & Ewa Robak. (2006). Purine Nucleoside Analogs as Immunosuppressive and Antineoplastic Agents: Mechanism of Action and Clinical Activity. Current Medicinal Chemistry. 13(26). 3165–3189. 111 indexed citations
12.
Robak, Tadeusz, Agnieszka Wierzbowska, & Ewa Robak. (2006). Recent Clinical Trials of Cladribine in Hematological Malignancies and Autoimmune Disorders. Reviews on Recent Clinical Trials. 1(1). 15–34. 18 indexed citations
13.
Robak, Ewa, Piotr Smolewski, Anna Woźniacka, Anna Sysa‐Jędrzejowska, & Tadeusz Robak. (2004). Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus. Mediators of Inflammation. 13(3). 171–180. 22 indexed citations
14.
Woźniacka, Anna, Ewa Robak, Anna Sysa‐Jędrzejowska, & Daniel P. McCauliffe. (2003). Pneumocystis carinii Mimicking Neonatal Lupus Erythematosus‐Related Pneumonitis. Pediatric Dermatology. 20(6). 524–528. 3 indexed citations
15.
Woźniacka, Anna, Anna Sysa‐Jędrzejowska, Ewa Robak, & Małgorzata Żak-Prelich. (2002). [Drug eruptions].. PubMed. 59(3). 183–9. 1 indexed citations
16.
Robak, Tadeusz, H Urbańska-Ryś, Ewa Robak, et al.. (2002). Aggressive Primary Plasma Cell Leukemia with Skin Manifestations, Trisomy 8 and Molecular Oligoclonal Features. Leukemia & lymphoma. 43(5). 1067–1073. 8 indexed citations
17.
Waszczykowska, Elżbieta, et al.. (1999). Estimation of SLE Activity Based on the Serum Level of Chosen Cytokines and Superoxide Radical Generation. Mediators of Inflammation. 8(2). 93–100. 31 indexed citations
18.
Robak, Ewa, et al.. (1998). Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.. PubMed. 46(6). 375–80. 27 indexed citations
19.
Robak, Ewa, Anna Sysa‐Jędrzejowska, H Stępień, & Tadeusz Robak. (1997). Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus.. PubMed. 8(3). 281–6. 39 indexed citations
20.
Robak, Tadeusz, Ewa Robak, & Anna Sysa‐Jędrzejowska. (1995). La hora neocon. Revista de libros. 26(2). 145–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Tébib Breakdown of academic impact, for papers by Frances Humby Breakdown of academic impact, for papers by Jerzy Świerkot Breakdown of academic impact, for papers by Scott W. Baumgartner Breakdown of academic impact, for papers by Carla A. Wijbrandts Breakdown of academic impact, for papers by J S Smolen Breakdown of academic impact, for papers by Seung Cheol Shim Breakdown of academic impact, for papers by Jonathan S. Coblyn Breakdown of academic impact, for papers by Alberta Hoi Breakdown of academic impact, for papers by Sergio Schwartzman
Rankless by CCL
2026